Phase 1 results for MST-01 demonstrate rapid symptom relief.
Company Description
Miist Therapeutics is a physics-based developer of inhaled medicines that has clinically validated its approach and is advancing two assets: MST-01 for smoking addiction and MST-02 for migraine treatment.
Market
Inhaled medicines for smoking addiction and migraine treatment
Location
Alameda,
California,
USA
Coinvestors
Refactor Capital, 1517 Fund, Freeflow Ventures, Entrepreneur First, California Innovation Fund